Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer

This study investigated the maximum tolerated dose (MTD) of S-1 with concurrent radiotherapy in patients with head and neck cancer, based on the frequency of dose-limiting toxicities (DLT). S-1 was administered orally at escalating doses from 40 mg/m(2) b.i.d. on the days of delivering radiotherapy,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nakata, Kensei, Sakata, Koh-ichi, Someya, Masanori, Miura, Katsutoshi, Hayashi, Junichi, Hori, Masakazu, Takagi, Masaru, Himi, Tetsuo, Kondo, Atsushi, Hareyama, Masato
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2013
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3709662/
https://ncbi.nlm.nih.gov/pubmed/23292146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jrr/rrs133
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak